Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy: A meta-analysis

BACKGROUND: Glioblastoma (GB) is one of the most common malignancies with limited standard therapies such as surgery, radiotherapy (RT) plus temozolomide (TMZ). Molecularly targeted drugs have been investigated among various clinical trials and are expected to develop in the field of tumor therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen-Lei, Aru, Na, Liu, Zhi, Shen, Xun, Ding, Yi-Ming, Wu, Shi-Ju, Qin, Huai-Hai, Jin, Wen-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855632/
https://www.ncbi.nlm.nih.gov/pubmed/31702627
http://dx.doi.org/10.1097/MD.0000000000017759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855632/
https://www.ncbi.nlm.nih.gov/pubmed/31702627
http://dx.doi.org/10.1097/MD.0000000000017759

Ejemplares similares